Aim: Type 2 diabetes mellitus (DM2) is a chronic disease caused by the underproduction of insulin in the organism and it is considered a risk factor to periodontal disease.
INTRODUCTION
Diabetes mellitus (DM) is a chronic disease that represents a disorder in the metabolism of glucose, carbohydrates, lipids, and proteins, and it is characterized by the inability of the organism to resist to or produce insulin. 1, 2 Diabetic patients present classic symptoms of the triad: Polydipsia, polyuria, and polyphagia, which are often associated with chronic fatigue and weight loss. 3 Diabetes is one of the most prevalent diseases in the world, and it has been dramatically increasing over the last decades. 4 Populations tend to show a constant increase in the incidence of the disease as age progresses. 5 It is estimated that 382 million people in the world suffer from diabetes, 6 which is one of the main causes of mortality and morbidity. 7 There are two types of diabetes.
Type 1 results from the underproduction of insulin that occurs by beta cell destruction in the pancreas. 3 On the other hand, Type 2 DM (DM2) is characterized by resistance to insulin, whereas aging, obesity, and family history are the main etiological factors. 5 The change in cell response is the result from the deficiency of insulin receptors. 2 Type 2 DM is the most common form of the disease, accounting for about 90% of all cases. 8, 9 ORIGINAL RESEARCH
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Due to its high prevalence worldwide, DM carriers often visit dental offices. 7 Several studies 4,9-12 have affirmed the relationship of DM with oral pathological processes, where periodontal disease is mostly associated. Several factors contribute to improve this relationship. 12 The production of glycation end products, changes the structure and metabolism of collagen, changes in immunological response, and interleukins activation are among the most common actions in decompensated diabetic patients, effectively contributing to the progression of periodontal disease. 12 Thus, the maintenance of periodontal tissue health contributes to an improved metabolic control, reducing the need for insulin and the levels of glycosylated hemoglobin.
6,7
Besides periodontal disease, several other oral manifestations are often associated with DM. 9 Hyposalivation, another common oral manifestation from the systemic condition, is characterized by the decreased production of saliva because of the hypofunction of salivary glands. 13 Changes in the parenchyma of these glands affect cell activity, reducing enzyme action, and causing disorders in saliva production. 14 Ulcers, cheilitis, and fissured tongue may be consequences presented in the oral cavity of diabetic patients. 9 Moreover, the change of oral microbiota in diabetic patients makes them prone to infections by Candida albicans. This predisposition may be due to xerostomia or immunosuppression. Xerostomia is considered one of the main signs of DM. Its occurrence causes discomfort and facilitates the establishment and development of carious disease. 15 Therefore, this study aimed to identify whether the prevalence and severity of oral diseases are higher in patients with DM2 than in nondiabetic patients.
MATERIALS AND METHODS
Before this research was performed, this study was approved by the Research Ethics Committee in Human Beings under protocol number 797/2005, and the participants signed an informed consent form regarding the objectives of the project. The total sample studied (250 patients) included a control group and an experimental group. At the Diabetes Outpatient Clinic of the School of Medicine [FM -University of Passo Fundo (UPF)], 116 patients were examined and formed the experimental group. At the Examinations, Triage, and Emergency Sector of the School of Dentistry (SETU/FO-UPF), 134 nondiabetic patients were examined and formed the control group. Inclusion criteria of the study were patients over 35 years old with DM2 for the experimental group and nondiabetics for the control group. Pregnant patients were excluded from the study.
The DM was diagnosed through the criteria proposed by the World Health Organization 16 and by the Guidelines of the Brazilian Society of Diabetes. 17 According to fasting glycemia and 2 hours after 75 mg glucose overload (postprandial glycemia), the individuals were classified into the following categories: Compensated patients (fasting glycemia ranging between 70 and 110 mg/dL of blood, and postprandial glycemia up to 170 mg/dL of blood); compensated patients, but with decreased tolerance to glucose (fasting glycemia ranging from 110 to 126 mg/dL of blood and postprandial glycemia up to 170 to 199 mg/dL of blood); decompensated patients (fasting glycemia higher than or equal to 126 mg/dL of blood, and postprandial glycemia higher than or equal to 200 mg/dL of blood).
For clinical examination, all anatomical sites were analyzed (lips, tongue, gingiva, and palate) and information was filled out on proper clinical records by two previously trained examiners. In addition, a questionnaire was applied to assess the following variables: Gender, age, socioeconomic status, level of oral hygiene, quality of saliva, use of insulin or other antidiabetics, allergies to medicines or other substances, smoking habit, normality of blood pressure, presence of cardiovascular and/ or renal diseases, use of dental prosthesis, daily tooth brushing frequency, use of dental floss, number of active caries, periodontal disease, and xerostomia.
Before this study was performed, an intra and interexaminer training was carried out, as well as a pilot study with 20 patients (10 patients from the SETU/FO-UPF, and 10 patients with DM2 from the diabetes outpatient clinic of the FM-UPF). Kappa test was used to assess interexaminer reproducibility, which resulted in 80% concordance.
Data collected were statistically analyzed by the Statistical Package for the Social Sciences (18.0 for Windows™) software with a qualitative research focus, and statistical analysis was performed through the chisquare test at 5% and relative risk index (odds ratio). Table 1 shows data concerning age, gender, and presence or absence of DM2 in the research participants. This table showed that 96 individuals were men and 154 were women (p = 0.052). Among diabetic patients, only 33 were between 35-and 50-year-old and 83 were over 50-year-old.
RESULTS
Most diabetic patients examined were over 50-yearold (n = 83), while nondiabetics (n = 79) were between 35-and 50-year-old, with statistically significant difference (p = 0.00). There was no statistical difference when relating gender to the presence or absence of diabetes (p = 0.052), where 64 were women and 52 were men.
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The risk index of the sample indicated that patients over 50-year-old had 3.613 times higher risk of developing DM2 than patients from 35-to 50-year-old. The confidence interval obtained by logistic regression for the association between DM2 and age was 2.126 to 6.139.
Insulin-dependent diabetic patients presented higher rate of oral pseudomembranous candidiasis than diabetic patients who did not use insulin as shown in Table  2 . Table 3 shows that patients with DM2 presented higher prevalence of xerostomia than nondiabetic patients.
Diabetic patients who used complete upper denture presented higher prevalence of prosthetic stomatitis than nondiabetics (p = 0.006). The estimated risk and confidence interval obtained by logistic regression for the association between DM2 and prosthetic stomatitis in complete upper denture users was 7.442 times higher, with confidence interval of 2.971. Table 4 shows that from 116 diabetic patients examined, 7 presented clinical signs of oral reticular lichen planus, while none of the nondiabetic patients presented such disease.
DISCUSSION
This study aimed to identify whether the prevalence and severity of oral diseases are higher in patients with DM2 than in nondiabetic patients. Hence, it is possible to verify that the risk index for the development of oral lesions, such as prosthetic stomatitis, xerostomia, and pseudomembranous candidiasis was higher in diabetic patients than in nondiabetics, especially for patients over 50-year-old, who demanded more attention from dentists regarding this disorder.
The DM2 is a highly prevalent chronic disease characterized by resistance to insulin, where aging, obesity, and family history are the main etiological factors. 2 Such condition was described as a new global epidemic, constituting one of the main public health challenges of the 21st century. 18 It is estimated that 382 million people in the world suffer from diabetes, 6 which is one of the main causes of mortality and morbidity. 7 Hence, a series of oral lesions have been associated with DM2. The endocrine system plays an essential role in regulating several bodily processes through secretion and regulation of hormones, including those inside the oral cavity. 19 More than 20% of adults over 60-year-old have diabetes, and Type 2 is more prevalent in this group. Besides the increased potential to develop periodontitis, diabetic patients may present other oral complications related to diabetes, such as xerostomia, oral burning syndrome, candidiasis, defective wound healing, increased tendency to infections, decreased salivary flow, and salivary gland enlargement. 4, 19 Such affirmations agree with the findings of this study, considering that in our sample, In three subjects of the study it was not possible to obtain data about xerostomia patients over 50-year-old presented significantly more DM2 than younger patients (p = 0.00), showing 3.613 times higher risk of developing the endocrine disorder (Table 1) . It is known that diabetic patients have a higher risk of acquiring opportunistic infections since there are changes in oral microbiota and the immunological system. 15 Such increased risk may also be due to the presence of xerostomia or immunosuppression. 15 The primary cause is related to reduced salivary flow, which leads to the reduction of immunoglobulin levels in saliva, decreasing the immunological defense mechanism mediated by the humoral factor for controlling Candida infection. Therefore, we verified a higher rate of pseudomembranous candidiasis in insulin-dependent diabetic patients that in diabetic patients who did not use insulin (p = 0.00) ( Xerostomia is characterized by decreased salivary secretion, and this condition is considered one of the main signs of DM. 15 Its occurrence causes discomfort and facilitates the establishment and development of carious disease. 15 Several studies 13, [21] [22] [23] have reported the association between xerostomia and DM2. A study 22 including 391 patients with DM2 and 391 individuals constituting the control group suggested that decompensated patients present a significantly higher prevalence than metabolically controlled patients (p < 0.05). 22 The information obtained in this study agree with such findings since we observed that patients with DM2 presented higher prevalence of xerostomia (n = 55) than nondiabetic patients (n = 27) (p = 0.00) ( Table 3) . On the contrary, by studying a universe of 30 patients, authors 21 found the presence of xerostomia in only one patient, which disagrees with our work. Such a contradiction may be explained by the low sample number assessed by the study in question. It is worth noting that this study did not measure the amount of saliva in patients, and the presence or absence of xerostomia was determined by the sensation of "dry mouth" reported by patients. The use of complete upper denture is relatively common in older patients. However, the deficiencies of such appliance, yeast infections, or poor oral hygiene may promote prosthetic stomatitis. 24 This lesion is characterized by an erythematous lesion confined to the prosthesis area and may present painful symptomatology. 24 In our study, diabetic patients with complete upper denture presented more prosthetic stomatitis than nondiabetics (p = 0.006). Several studies 19, 22 corroborate our results.
Al-Maweri et al 22 found highly significant results for prosthetic stomatitis in diabetics compared with nondiabetics (p = 0.018). Thus, it is possible to suggest there is a significant association between metabolic control of DM2 and oral lesion since diabetic patients with complete upper denture showed 7.442 times higher risk than nondiabetics for developing prosthetic stomatitis. In this work, from the 116 diabetic patients examined, 7 presented clinical signs of oral lichen planus, while none of the nondiabetic patients presented such disease. Thus, it was possible to observe a significant relationship between DM2 and oral lichen planus (p = 0.004). In a study 25 with 80 carriers of lichen planus, wherein 16 (20%) were diabetics, the results also showed a statistically significant relationship (p = 0.001), agreeing with this study. Moreover, the said authors 25 suggested that the duration of lichen planus lesions in diabetic patients was significantly longer when compared with the lesions in nondiabetic patients. This is probably caused by the difficulty of tissue repair of lesions, which is considered a typical characteristic of diabetic patients. Thus, our work highlights a significant association between DM2 and oral lesions, especially pseudomembranous candidiasis, lichen planus, lingual varices, xerostomia, and prosthetic stomatitis (p > 0.001). We believe that the results, hereby, reported are of vital importance for establishing new conducts with greater emphasis on diabetic patients. Hence, further studies should be performed to confirm and reinforce such findings.
CONCLUSION
The patients with DM2 from the sample studied presented higher risk index for developing oral lesions than nondiabetics, especially pseudomembranous candidiasis, lichen planus, lingual varices, xerostomia, and prosthetic stomatitis.
